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Research ethics review is an important process,
designed to protect participants in medical research.
However, it is increasingly criticised for failing to meet its
aims. Here, two researchers reﬂect on their experiences
of applying for ethical approval of observational research
in clinical settings. They highlight some problems faced
by reviewers and researchers and propose a two-stage
ethical review process that would alert researchers to
the committee’s concerns and allow them to give a more
considered response.
‘The purpose of a REC in reviewing the proposed
study is to protect the dignity, rights, safety and
well-being of all actual or potential research
participants.’
1
Historical examples demonstrate both the need
for some means of ensuring that research partici-
pantsarenotmistreatedandthefactthatregulatory
frameworks do not always achieve this aim.
2 3
Formal processes for reviewing proposed research
involving human participants have been developed
in recent years, although the precise details vary
between different countries. For example, in
Australia individual hospitals are required to
constitute a human research committee in accor-
dance with the National Health and Medical
Council requirements. However, in practice indi-
vidual committees may not be properly constituted
and therefore may lack necessary expertise and,
moreover, the lack of a coordinated approach may
impede the conduct of large multicentre trials.
4 The
UK, by contrast, has developed a centralised coor-
dinated system of research ethics committees (REC)
toreviewresearchthatrecruitsthestaffandpatients
of the National Health Service as participants. The
committees of seven to 18 members are constituted
to include at least one-third ‘lay’ members while the
remainingmembersarespecialistsincludingdoctors,
other healthcare professionals and academics.
5
Despite these differences, the regulatory processes
that have been developed in a variety of highly
economically developed countries have been criti-
cised, both for failing to protect participants and for
stiﬂing worthwhile research.
6e10
Reforms in the UK, including a move from self-
regulation to political control, have been criticised
for transforming ethics review into a symbolic
activity centred on completing and approving
paperwork, with little to do with the control of
risks to research subjects.
8 Similarly, researchers
from Australia and New Zealand have described the
development of an institutional discourse of ethics,
which requires researchers to give certain ‘right’
answers and may inhibit the exploration of new
ways of conducting research that respect the needs
and values of hard-to-reach participants.
10 11
In this paper, we describe two doctoral applica-
tions to UK National Health Service REC that were
not granted ethical approval. We consider our
experiences from the emerging perspective intro-
duced above, in the hope that others will learn from
our accounts.
ETHICS COMMITTEES: TOOTHLESS OR TOO
FIERCE?
Dissatisfaction with current processes takes two
forms. Some authors argue that they are too weak,
favouring the facilitation of research over the
protection of lives and the dignity and welfare of
research participants.
6 7 However, recent criticism
raises a counterargument: processes are too
restrictive. REC have been accused of unjustiﬁed
paternalism and academics claim that over-
regulation is stiﬂing research.
12 13 A recent UK
study found that only approximately 17% of
applications receive approval at ﬁrst consideration
(data are based on the period October 2005eMarch
2008 from the National Research Ethics Service
website and refer to all applications).
14
In the face of this criticism, REC and their
regulators in government (the UK National
Research Ethics Service is part of the National
Patient Safety Agency, a body of the UK govern-
ment’s Department of Health) have been compelled
to attempt a delicate balancing act. On the one
hand, REC must ensure that potential participants
are adequately protected from unjustiﬁed risks. On
the other hand, they must avoid overly paternal-
istic interference with the agency of potential
participants. Moreover, the correct balance is
a matter of judgement rather than fact; determined
by the relative value placed on principles such as
‘protecting wellbeing’ and ‘respecting autonomy’.
In the remainder of this paper we describe the ways
in which different conceptions of these principles
are enacted in the process of conducting ethical
review, highlight some difﬁculties that arise
when attempting to negotiate plurality of values in
the context of institutional mandates, and make
some practical suggestions that might help
researchers and reviewers in the future.
REVIEWERS’ CONCERNS
A brief description of the two projects is given in
Box 1
In line with General Medical Council guidance and
current research practice, both protocols proposed
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Research ethicsthat consent from all participants be sought in two stages,
before recording took place and afterwards.
16 This would enable
participants to decide whether they wanted recordings to be
analysed once they were aware of the content.
Initial consent (or assent in cases in which potential partici-
pants lacked capacity) would be sought before recording the
encounters. Both REC, following accepted practice guidelines,
considered it unacceptable to approach potential participants
immediately before the clinical encounter to be observed. REC 1
suggested including patient information sheets and a reply slip
with appointment letters, to be returned indicating whether
patients wished to opt in or out of the study. REC 2 considered
it unlikely that a service user involved in a Mental Health Act
(MHA) assessment would have ‘the capacity to make a rational
decision’ about participation and suggested approaching service
users in remission, to seek advance consent for participation
should they become the subject of a MHA assessment in the
future.
Both REC expressed concern about the two-stage consent
process, but for different reasons. REC 1 suggested a three-stage
process, seeking consent for recording in advance and consent for
analysis immediately after the appointment and again 1 week
later. In contrast, REC 2 considered it unacceptable to approach
participants after the recording as they may be either unable or
unwilling to recall the MHA assessment.
Recording clinical encounters
Study 1 would have used videorecording, allowing collection of
data on non-verbal communication. Study 2 would have used
audiorecording supplemented by handwritten ﬁeld notes, a more
practical method for collecting data in the acute psychiatric care
setting.
Both REC expressed concern that the act of recording would
interfere with clinical care, either by inhibiting doctorepatient
discussion (study 1) or damaging the therapeutic relationship
and reinforcing persecutory beliefs (study 2).
REC 1 considered the use of videorecording unacceptable on
the grounds that, in comparison with audiorecording, it would
involve collecting more data than was needed to answer the
research questions. Videorecording is, however, generally
considered good practice whenever possible in studies involving
the microanalysis of data.
REC 2 expressed concern about the nature of the encounter to
be audiorecorded, characterising it as being inherently sensitive,
‘like childbirth’, and considered it unacceptable to record such an
encounter. The application cited numerous studies that have
successfully used recordings of equally sensitive interactions to
improve practice.
17 18 The committee did, however, think it
acceptable for an observer to be present and to take notes.
REC 2 expressed additional concerns about the possible
consequences for clinicians, citing the possibility that service
users may ‘demand to hear the tapes or for them to be released
to be used in court proceedings’.
Maintaining conﬁdentiality
Study 1 proposed the use of a healthcare transcription agency,
bound by a conﬁdentiality agreement, to maximise time avail-
able for analysis. REC 1 did not agree to this arrangement, citing
concerns about increased risk of breach of conﬁdentiality.
In accordance with good practice in qualitative research, both
studies proposed the sharing of researcher-selected anonymised
extracts with other researchers and (in the case of study 1) focus
groups of clinicians, to improve the credibility of the qualitative
analysis. This would be done only with the explicit consent of
participants. Both REC considered this unacceptable. REC 1
took the view that this practice risked participant conﬁdentiality
and would be scientiﬁcally ﬂawed, and suggested conducting
a purely quantitative content analysis focused on the question‘is
summary used in practice?’ REC 2 also took the view that this
practice would represent an unacceptable risk to participant
conﬁdentiality. They expressed the belief that recordings could
never be effectively anonymised, due to the risk that the sound
of the speaker’s voice may be recognised, and suggested
conducting an interview-based study instead of observation.
RESEARCHERS’ REFLECTIONS
We wholeheartedly agree that it is important that REC are
committed to the protection of potential research participants
and take a robust approach to the consideration of risk. As such,
we formed both positive and negative impressions of the ethics
review process.
As we were both inexperienced in our methodologies we were
pleased that our proposals were scrutinised and that we were
not given an ‘easy ride’ by the committees. However, we both
felt overwhelmed during our meetings with the committees.
The effect of this was that we felt put on the spot and unable
effectively to voice an effective defence of our protocols, even
when we believed the committee had made factual misunder-
standings or when divergent evaluations of the risk to partici-
pants represented legitimate areas for debate. We do not suggest
that committee members intended to intimidate, rather that
features of the process, such as the size of the committees and
the time available for discussion may have the effect of silencing
applicants when values diverge.
We appreciated the willingness of committee members to
assist us by suggesting alternative ways in which the research
questions could be addressed. However, on reﬂection, we were
left with concerns about the practice of suggesting modiﬁcations
to protocols for a number of reasons.
The REC suggested that the studies be re-conceptualised as
a pilot study (study 1) and an audit (study 2). Ethical approval is
not required for audit and service evaluation studies in the
National Health Service. The response of committee 1 indicated
that they believed their approval would not be required for
a pilot study. The minutes of the review stated that ‘the
Committee felt strongly that the study should be structured
initially as a pilot study. This would help understand whether
the method of approaching patients and doctors is appropriate
and if data collection would be practicable in a larger study..I f
the pilot study is positive then another application could be
submitted.’ While the committees’ suggested approaches would
make it easier to conduct the research, as ethical approval would
no longer be required, it would also remove some of the safe-
guards for participants. These experiences may be instantiations
of the transformation of ethics review into symbolic activity. We
wonder whether these suggestions arose from a dilemma that
REC ﬁnd themselves in: anxious to facilitate research that seems
worthwhile but aware of their accountability to a complex and
seemingly inﬂexible regulatory process if they grant approval.
Promoting the continuation of research ‘by other means’ may be
their solution.
We felt that the suggested modiﬁcations to the consent
process may have been based upon a misinterpretation of stat-
utory regulations and professional guidelines. This interpreta-
tion is supported by evidence that REC in the UK have had
difﬁculty interpreting the Mental Capacity Act, 2005, and
have given advice to applicants that was not consistent with
the provisions of the Act.
11 For example, REC 2 may have
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Research ethicsmisinterpreted the principles of the Mental Capacity Act, 2005,
and made a presumption of incapacity, rather than capacity to
consent.
Studies of the experiences of health researchers demonstrate
that governance procedures can favour quantitative and clinical,
over qualitative and experiential, research.
19 This perspective
was reﬂected in our experiences. Study 1 was critiqued in front
of REC 1 predominantly by two members who adopted
a perspective based in the positivist paradigm, leading the
committee to recommend a quantitative study focusing only on
the question ‘is summary used in practice?’ REC 2’s suggestion
that observational/recorded data could be replaced by interview
data suggest that they had not fully appreciated the importance
of collecting objective recorded data on what was actually said
during assessments, rather than studying post-hoc accounts.
Modiﬁcation of protocols may be driven by divergence of values.
Both researchers and reviewers may have made the error of
assuming that potential participants would share their own
values, and that research that enacts their own values is there-
fore ‘ethical’. All of the criticisms of the REC outlined in this
paper could be viewed as instances of differences of opinion
regarding the appropriate evaluation of conﬂicting principles
during the construction of an understanding of ‘ethical
research’:
1. REC 1’s recommendation that information sheets be sent out
with appointment letters reﬂects a conception of autonomy
that favours minimising the possibility of undue inﬂuence
over building trusting relationships by giving opportunities to
discuss the study and ask questions.
20
2. REC 1’s recommendation of a three-stage consent process
prioritises protection of participants from potential harm
over respect for their autonomous decisions.
3. In contrast, REC 2’s recommendation of a one-stage consent
process could be viewed as prioritising protection from the
potential harm of being reminded of an unpleasant experience
over maximising opportunities for autonomous decision-
making.
4. The concerns expressed by both REC about the collection of
recorded data could be viewed as enactments of particular
evaluations of the invasiveness and risks of being recorded
and the potential beneﬁts of using such data.
Finally, these reconstructions of protocols to match the
committees’ conceptions of ‘ethical research’ may, paradoxically,
promote practice that is less respectful of the needs of partici-
pants. Busy clinicians may be presented with detailed informa-
tion sheets that they do not have time to read. Users of mental
health services may disengage from treatment through fear of
being made subject to involuntary treatment in the future.
Outpatients may be irritated or feel patronised by repeated
requests for conﬁrmation of their consent. More fundamentally,
possibilities for conducting the kind of observational research
that can shed light on practices that usually only occur behind
closed doors may be lost, along with the opportunity for
evidence-based improvements. In future, traditional ethical
review processes might be supplemented by a dialogical process
that encourages both researchers and reviewers to reﬂect on the
values enacted in the protocol and how they might affect
potential participants.
21
WHAT WE HAVE LEARNT
Our key learning points for novice researchers are given in Box 2
We also propose a change to the ethical review process. Perhaps,
doctoral research should have a two-stage ethical review process.
The researcher would be initially contacted by one member of
the committee to discuss their proposal and highlight areas the
committee will need them to address. This meeting would
provide an opportunity to: explain brieﬂy the process of the REC
meeting itself; outline expectations of the researcher; enable
Box 1 Two case studies of failure to obtain ethical
approval
Summaries of the proposed research projects
Study 1: a study of the use of the communication skill ‘summary’
in doctorepatient interactions. The aim was to investigate how
often summary is used during outpatient appointments, what
prompts its use and what effect it has on clinical interactions. The
participants would have been medical practitioners and patients
attending appointments in the medical and surgical clinics of
a teaching hospital. People who lacked capacity to consent to
participation would not be included. The protocol was reviewed
by REC 1.
Study 2: a study of the process of MHA assessments. The aim
was to investigate the application of new legislation by
describing how patients and clinicians represent their views of
whether compulsory treatment is needed and how the interaction
affects the weight those views are given. The participants would
have been clinicians and service users involved in MHA
assessments. People who lacked the capacity to consent to
participation would not necessarily be excluded: the procedures
and safeguards laid out in the Mental Capacity Act, 2005, would
be followed.
15 The protocol was reviewed by REC 2.
Both studies used established methodologies committed to the
analysis of naturally occurring interaction in order to investigate
what people actually do in clinical encounters (discourse analysis
and conversation analysis). Therefore, both proposed the
recording and transcribing of clinical encounters, to collect an
objective record of what people said and investigate the effect
this had on outcomes.
Box 2 Key learning points for researchers
< Don’t assume detailed knowledge of law or codes of practice.
Providing these in advance and quoting relevant sections
verbatim may help the committee, which will consist of lay
members, clinicians and scientists.
< Take great care explaining methodology, especially if you
diverge from the dominant paradigm of clinical trials into areas
where the committee may have less experience.
< Consider whether or not to attend alone. Novice researchers
may feel more conﬁdent defending their protocols to
a committee of 12 members (the norm for a UK NHS REC)
if they are accompanied by an advisor or supervisor.
< Keep an open mind. A divergence in values between you and
the committee is not a personal attack on you. Their opinions
are valid and deserve consideration.
< Don’t give up. Although only a minority of protocols receive
approval on ﬁrst consideration, the majority are approved
following amendments; we have both now had projects
successfully approved by ethics committees.
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Research ethicsfamiliarisation with the application; provide an atmosphere
more conducive to debate about divergent value judgements and
enable the researcher effectively to prepare for the REC meeting.
While this approach would be more time consuming and
expensive, we feel it is worth considering on the grounds that it
might reduce researchers’ sense of preparing to be thrown into
the ‘lion’s den’, open up lines of enquiry, and encourage others to
follow in their footsteps. Ultimately, this could lead to the
production of better quality, ethically justiﬁable research in the
future.
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